William Santis, MD
Urology · Concord, NHNPI 1558302281
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (55.6%), travel and lodging and education — rather than concentrated in one kind of arrangement. 6 manufacturers reported payments, led by Medtronic at 56.1% of the total. Reporting peaked in 2024 at $680 and has fallen 94.6% since, to $37 in 2025.
Across 17 payments — averaging $63.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$604
- Intuitive Surgical$360
- Boston Scientific$37
- Pfizer$34
- Davol Inc.$21
- Progenics Pharmaceuticals, Inc.$20
What the payments were for
- Travel & lodging$44441%
- Food & beverage$59956%
- Education$343%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 9 | $604 |
| Intuitive Surgical | 3 | $360 |
| Boston Scientific | 1 | $37 |
| Pfizer | 2 | $34 |
| Davol Inc. | 1 | $21 |
| Progenics Pharmaceuticals, Inc. | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Signia$299
- Da Vinci Surgical System$192
- LigaSure$145
How this compares
$1,077 in reported general payments places this provider in the 55th percentile of 61 urology providers in New Hampshire.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 16 | $11,384 |
| Tamsulosin Hcl | 219 | $2,536 |
| Tolterodine Tartrate ErTolterodine Tartrate | 17 | $1,495 |
| Dutasteride | 34 | $1,054 |
| Oxybutynin Chloride ErOxybutynin Chloride | 17 | $944 |
| Finasteride | 68 | $856 |
| Potassium Citrate ErPotassium Citrate | 24 | $641 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 32 | $604 |
| Cephalexin | 19 | $98 |
| Ciprofloxacin Hcl | 21 | $55 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 16 | $37 |
| Tadalafil | 14 | $29 |
Paid to pharmacies, not to this prescriber.
Other urology in Concord
- Ramiro Madden-FuentesConcord$82K
- Scott FabozziConcord$863
- Robert MitchellConcord$732
- Veronica TriacaConcord$676
- Michael RezaeeConcord$647
- Eileen BrandesConcord$635
- Amichai KilchevskyConcord$397
- Ronald YapConcord$70
- Paul SnyderConcord$20
- Christopher OrtengrenConcord$0
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.